The applicant asserted that the Axoguard HA+ Nerve Protector TM demonstrates clinical improvement in: (1) nerve health in an injured tissue bed through less adhesion, extraneural scarring, and inflammatory markers, (2) nerve health in an injured tissue bed through decreased friction between the nerve and surrounding tissue to allow for gliding and to minimize potential for soft tissue attachment, (3) device performance due to its sodium hyaluronate and sodium alginate gel layer that allows for nerve gliding, and (4) sensory and motor symptoms
The advanced facilities and technology we use
INGREDIENTS Cocus Nucifera, Water, Glycerin, Sodium Hydroxide, Coconut Diethanolamide, Sodium Lactate, Carica Papaya Extract, (Butylene Glycol, Water (Aqua), Kojic Acid, Acetyl Tyrosine, Sodium Sulfite, Aminipropyl Ascorbyl Phosphate, Saxifraga Sarmentosa Extract, Arbutin, Paeonia Suffroticosa Root Extract, Scutellaria Baicalensis Root Extract, Glutathione, EDTA, Butylated Hydroxytoluene Fragrance, CI5510
The logic behind combining Cagrilintide with a GLP-1 agonist is straightforward